Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John Abraham

Showing results (1-10 of 111) with videos related to

Pageof 12
Sort By:
International Journal of Hyperthermia : the Official Journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group|April 26, 2019
Heat risks associated with synthetic athletic fieldsJohn Abraham
Sociology of Health & Illness|July 23, 2011
Evolving sociological analyses of 'pharmaceuticalisation': a response to Williams, Martin and GabeJohn Abraham
Sociology of Health & Illness|September 3, 2008
Sociology of pharmaceuticals development and regulation: a realist empirical research programmeJohn Abraham
BMJ (Clinical Research Ed.)|September 10, 2005
Regulating the drugs industry transparentlyJohn Abraham
Social Science & Medicine (1982)|September 26, 2002
Transnational industrial power, the medical profession and the regulatory state: adverse drug reactions and the crisis over the safety of Halcion in the Netherlands and the UKJohn Abraham
Australian Health Review : a Publication of the Australian Hospital Association|November 6, 2004
Pharmaceuticals, the state and the global harmonisation processJohn Abraham
Social Science & Medicine (1982)|January 9, 2010
On the prohibition of conflicts of interest in pharmaceutical regulation: precautionary limits and permissive challenges. A commentary on Sismondo (66:9, 2008, 1909-14) and O'Donovan and LexchinJohn Abraham
Social Science & Medicine (1982)|January 18, 2015
Accuracy and progress in the analytics of pharmaceuticalization: a response to Davis (2014)John Abraham
Lancet (London, England)|November 16, 2002
The pharmaceutical industry as a political playerJohn Abraham
Sociology|August 1, 1994
Bias in science and medical knowledge: the Opren controversyJohn Abraham
Pageof 12

Showing results (1-10 of 111) with videos related to

Sort By:
Pageof 12
International Journal of Hyperthermia : the Official Journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group|April 26, 2019
Heat risks associated with synthetic athletic fieldsJohn Abraham
Sociology of Health & Illness|July 23, 2011
Evolving sociological analyses of 'pharmaceuticalisation': a response to Williams, Martin and GabeJohn Abraham
Sociology of Health & Illness|September 3, 2008
Sociology of pharmaceuticals development and regulation: a realist empirical research programmeJohn Abraham
BMJ (Clinical Research Ed.)|September 10, 2005
Regulating the drugs industry transparentlyJohn Abraham
Social Science & Medicine (1982)|September 26, 2002
Transnational industrial power, the medical profession and the regulatory state: adverse drug reactions and the crisis over the safety of Halcion in the Netherlands and the UKJohn Abraham
Australian Health Review : a Publication of the Australian Hospital Association|November 6, 2004
Pharmaceuticals, the state and the global harmonisation processJohn Abraham
Social Science & Medicine (1982)|January 9, 2010
On the prohibition of conflicts of interest in pharmaceutical regulation: precautionary limits and permissive challenges. A commentary on Sismondo (66:9, 2008, 1909-14) and O'Donovan and LexchinJohn Abraham
Social Science & Medicine (1982)|January 18, 2015
Accuracy and progress in the analytics of pharmaceuticalization: a response to Davis (2014)John Abraham
Lancet (London, England)|November 16, 2002
The pharmaceutical industry as a political playerJohn Abraham
Sociology|August 1, 1994
Bias in science and medical knowledge: the Opren controversyJohn Abraham
Pageof 12